Navigation Links
CEL-SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1-Infected Patients
Date:9/23/2009

VIENNA, Va., Sept. 23 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE AMEX: CVM), a developer of vaccines and therapeutics for the treatment of infectious diseases and a late-stage oncology company, announced today that it has hired a full-service Clinical Research Organization (CRO) with an office in the Washington, D.C./Baltimore area to support its conduct of the upcoming clinical trial of its investigational LEAPS-H1N1 treatment. Last week, CEL-SCI announced that the U.S. Food and Drug Administration (FDA) had indicated that the Company can proceed with its first clinical trial to evaluate the effect of its investigational LEAPS-H1N1 treatment on the white blood cells of hospitalized H1N1 patients. This followed the very responsive and expedited initial review of CEL-SCI's regulatory submission for this study proposal by the FDA. Following completion of manufacturing, initiation of this first study is subject to IRB review and approval. The study will involve taking blood from hospitalized, laboratory-confirmed H1N1 patients and activating their cells with the LEAPS-H1N1 investigational therapy in order to assess the cells' response as the basis for the planned future treatment of this patient population under a next-stage clinical trial protocol.

In order for FDA to fully consider that next-stage clinical trial to evaluate LEAPS-H1N1 treatment of hospitalized patients with laboratory-confirmed H1N1 Pandemic Flu under an Exploratory IND, FDA has asked CEL-SCI to submit a detailed follow-up regulatory filing with extensive additional data. Thus, in parallel with ramping up its first study, CEL-SCI is proceeding on an expedited basis with the substantial undertaking necessary to complete this next submission. Recognizing that it cannot proceed with its next-stage clinical trial without the Agency
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
2. CEL-SCI Corporation Releases Letter to Shareholders
3. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
4. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
5. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
6. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI Corporation Announces 2007 Financial Results
9. CEL-SCI Corporation Reports First Quarter Financial Results
10. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
11. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... to a survey by KLAS, an independent research firm, ... the number one ranking in the medical and/or radiology ... report. The survey of 247 customers of various vendors ... take a commanding lead over their competitors." MOSAIQ scored ... they would buy again and 96 percent confirmed that ...
(Date:10/25/2014)... Oct. 24, 2014 Research and Markets ... Market Current Trends, Opportunities - Global Forecast to 2019" ... this report, the global dental equipment market is categorized ... systems and equipment market is expected to register the ... the forecast period (2014 to 2019). This high growth ...
(Date:10/25/2014)... , Oct. 24, 2014 Advanced Photonix ® ... (ending September 26, 2014) financial results on Monday, November 10, ... released after the close of the market and the Company ... results at 4:30 p.m. EDT on the same day. ... (CEO and Director), Rob Risser (COO and ...
Breaking Medicine Technology:Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 2Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 3Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Advanced Photonix to Webcast Fiscal 2015 Second Quarter Earnings 2
(Date:10/25/2014)... 26, 2014 LunaDress is excited to ... wedding dresses today. According to the company’s CEO, ... especially those dwelling in the UK. The company’s new ... They are all unpretentious and elegant. , These new ... inputs from top dress experts. LunaDress strives to provide ...
(Date:10/25/2014)... (PRWEB) October 26, 2014 Recently, ... best Joomla hosting suppliers of 2014. . According ... among the most excellent suppliers in the world. ... for webmasters to make money from hosting. The ... resources to host the others’ websites under a ...
(Date:10/25/2014)... Top 10 Best SEO Hosting is ... The site has recently compared many hosting companies and ... among the most reliable Linux web hosting companies in ... Best SEO Hosting says, “The hosting suppliers we recommend ... outperform their competitors on hosting features, uptime and server ...
(Date:10/25/2014)... 26, 2014 The past five ... Sugar Cane Growing industry in Australia . ... by extreme weather patterns, volatile commodity prices and ... industry analyst Brooke Tonkin, “Over the period, flooding ... of Australia's sugar cane crop.” Consequently, industry revenue ...
(Date:10/25/2014)... Diego, CA (PRWEB) October 25, 2014 ... synthetic biology, today announced Dr. Xun ... of all Research & Development. , Triton has developed ... high value algae-based proteins. According to Dr. Wang, the ... over traditional expression systems. He says, “Algae are unique ...
Breaking Medicine News(10 mins):Health News:LunaDress Now Release Its Designer Inspired Fashion Wedding Dresses For Customers Dwelling In The UK 2Health News:Top10BestSEOHosting.com: GoDaddy, Bluehost And Hostgator Are Among The Most Excellent Suppliers In The World 2Health News:Top 10 Best SEO Hosting Announces That GreenGeeks.com And HostMonster Are Among The Most Reliable Linux Web Hosting Companies In 2014 2Health News:Sugar Cane Growing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Cane Growing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 3
... Cosmecueticals, beauty aids that reportedly work like prescription drugs, ... study recently published in the Journal of Cosmetic Dermatology ... provide a visibly noticeable improvement in maturing skin. , ... the lack of skin surface regularity, formation of wrinkles, ...
... 28 Versus,Technology, Inc. ("Versus" or the "Company") ... October 31, 2007, compared to,revenues of $2,177,000 for ... year,ended October 31, 2007, were $5,566,000 compared to ... vary significantly depending on,the timing and delivery of ...
... MB Software,Corporation (OTC Bulletin Board: MBSB) announced ... Equity Partners to issue 490.196 shares of its,Series ... cancellation of,approximately $1,500,000 in debt. The debt was ... affiliates. The preferred stock will,automatically convert into an ...
... gadolinium-containing contrast injections in adults and pediatric patients (those ... to a recent study conducted by researchers at the ... these reactions do occur, most of them are mild, ... study. , Over the past few years, the ...
... Dec. 28 /PRNewswire-FirstCall/ - AlphaRx Inc. (OTC BB:ALRX,- ... for Drug Delivery,Platforms, announce that in order to ... directors, consultants and employees plan to,exercise stock options ... Lee, President and CEO, will cancel 6,000,000 options,granted ...
... 28 Lincare Holdings,Inc. (Nasdaq: LNCR ) today ... and Exchange Commission (the "SEC") a resale shelf registration,statement ... pursuant to the terms,of a registration rights agreement Lincare ... sale of its $275 million principal amount of,convertible senior ...
Cached Medicine News:Health News:Versus Technology Announces Fourth Quarter Results 2Health News:Versus Technology Announces Fourth Quarter Results 3Health News:Versus Technology Announces Fourth Quarter Results 4Health News:Versus Technology Announces Fourth Quarter Results 5Health News:Versus Technology Announces Fourth Quarter Results 6Health News:Versus Technology Announces Fourth Quarter Results 7Health News:MB Software Corporation Reaches Agreement with Keystone Equity Partners 2Health News:Allergic reactions to gadolinium-based contrast agents are rare, study finds 2Health News:AlphaRx Officers and Directors To Exercise Options, Warrants and Retain Shares 2Health News:Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement 2
... including the Ceralas D and SmilePro 980 ... medical, dental, and veterinary environments.,With unsurpassed, optimal ... nm laser series allow controlled tissue ablation ... surgical procedures. Unlike other medical lasers, biolitecs ...
... Assay is a second generation nucleic acid ... in vitro qualitative detection and differentiation of ... uses a family of Gen-Probe's proven technologies ... and Dual Kinetic Assay (DKA). This is ...
... The InTray™ GC is a ... detection of both Neisseria gonorrhoeae and ... a long shelf life and is ... system. Simply inoculate, incubate and ...
... designed for patients with a spherical hyperopia between ... who would benefit from a spherical treatment of ... a myopic endpoint of between -1.00 D and ... improve near vision. CK is unique in that ...
Medicine Products: